The Modern Era of Heart Failure

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Iki Adachi, MD
Disclosure(s): Abiomed Inc.: Advisory Board (Ongoing)

Joseph Turek, MD, PhD, MBA

Presentations

  1. Outcomes in Children with Congenital Heart Disease who Undergo Post-cardiotomy Extracorporeal Membrane Oxygenation; a Report from the Society of Thoracic Surgeons National Database
    Tanya Perry, DO
     
  2. Berlin Heart As a Bridge to Transplant in Patients Aged 5 and Under
    Zachary Brennan, DO
     
  3. Pediatric Interagency Registry For Mechanical Circulatory Support (PEDIMACS) Report: Predicting Stroke For Pediatric Patients Supported With Ventricular Assist Devices
    Awais Ashfaq, MD
     
  4. Differences in Outcomes and Survival in Pediatric Patients with Acquired and Congenital Heart Disease: A Study of those Bridged to Heart Transplantation with the Berlin Heart Ventricular Assist Device
    Ahmet Bilgili
     
  5. Post-Transplant Survival for Patients with MCS and Complications is Similar to MCS Patients Without Complications
    Kevin Kulshrestha, MD, MBE
     
  6. How I do it: Pediatric Donation after Cardiac Death using Normothermic Regional Perfusion
    Douglas M. Overbey, MD, MPH
     
  7. Panel Discussion and Audience Q&A
    Mark S. Bleiweis, MD

    Katsuhide Maeda, MD, PhD

    Disclosure(s): Medtronic, Edwards, Boston Scientific, Abbott: Consultant (Ongoing); Abiomed: Consultant (Ongoing); Berlin Heart: Consultant (Ongoing); JOMDD: Consultant (Ongoing); Peca Lab: Consultant (Ongoing)

    Cynthia Herrington, MD
Activity summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation
Activity opens: 
02/01/2024
Activity expires: 
02/15/2027
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Iki Adachi, MD
Disclosure(s): Abiomed Inc.: Advisory Board (Ongoing)

Joseph Turek, MD, PhD, MBA

Presentations

  1. Outcomes in Children with Congenital Heart Disease who Undergo Post-cardiotomy Extracorporeal Membrane Oxygenation; a Report from the Society of Thoracic Surgeons National Database
    Tanya Perry, DO
     
  2. Berlin Heart As a Bridge to Transplant in Patients Aged 5 and Under
    Zachary Brennan, DO
     
  3. Pediatric Interagency Registry For Mechanical Circulatory Support (PEDIMACS) Report: Predicting Stroke For Pediatric Patients Supported With Ventricular Assist Devices
    Awais Ashfaq, MD
     
  4. Differences in Outcomes and Survival in Pediatric Patients with Acquired and Congenital Heart Disease: A Study of those Bridged to Heart Transplantation with the Berlin Heart Ventricular Assist Device
    Ahmet Bilgili
     
  5. Post-Transplant Survival for Patients with MCS and Complications is Similar to MCS Patients Without Complications
    Kevin Kulshrestha, MD, MBE
     
  6. How I do it: Pediatric Donation after Cardiac Death using Normothermic Regional Perfusion
    Douglas M. Overbey, MD, MPH
     
  7. Panel Discussion and Audience Q&A
    Mark S. Bleiweis, MD

    Katsuhide Maeda, MD, PhD

    Disclosure(s): Medtronic, Edwards, Boston Scientific, Abbott: Consultant (Ongoing); Abiomed: Consultant (Ongoing); Berlin Heart: Consultant (Ongoing); JOMDD: Consultant (Ongoing); Peca Lab: Consultant (Ongoing)

    Cynthia Herrington, MD